Portal:CPTAC

From WikiPathways

(Difference between revisions)
Jump to: navigation, search
(changed margins to give hallmark sections more room)
Line 9: Line 9:
}}
}}
-
<div style="float:left; width:68%"> <!-- This width add to the the margin below to equal 99%-->
+
<div style="float:left; width:73%"> <!-- This width add to the the margin below to equal 99%-->
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal
Line 23: Line 23:
</div>
</div>
-
<div style="float:right; width:31%"> <!-- This margin should be right of the above -->
+
<div style="float:right; width:26%"> <!-- This margin should be right of the above -->
{{{{FULLPAGENAME}}/box-normal
{{{{FULLPAGENAME}}/box-normal

Revision as of 21:23, 4 October 2017

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

The pathways included in this portal have been organized into classic cancer hallmark categories, based on the different biological capabilities acquired during the multistep development of human tumors. To read more, see Hallmarks of cancer: the next generation, Hanahan and Weinberg, Cell 2011.

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling

FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma (Homo sapiens)

Image does not exist
FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma
Evading growth suppressors

TGF-beta signaling (Homo sapiens)

Image does not exist
TGF-beta signaling
Activating invasion and metastasis

Epithelial to mesenchymal transition in colorectal cancer (Homo sapiens)

Image does not exist
Epithelial to mesenchymal transition in colorectal cancer
Enabling replicative immortality

Notch signaling (Homo sapiens)

Image does not exist
Notch signaling
Inducing angiogenesis

Angiogenesis (Homo sapiens)

Image does not exist
Angiogenesis
Resisting cell death

Target of rapamycin signaling (Homo sapiens)

Image does not exist
Target of rapamycin signaling
Deregulating cellular energetics

TCA cycle nutrient use and invasiveness of ovarian cancer (Homo sapiens)

Image does not exist
TCA cycle nutrient use and invasiveness of ovarian cancer
Genome instability and mutation

DNA IR-damage and cellular response via ATR (Homo sapiens)

Image does not exist
DNA IR-damage and cellular response via ATR
Tumor promoting inflammation

IL6 signaling (Homo sapiens)

Image does not exist
IL6 signaling
Avoiding immune destruction

Type II interferon signaling (Homo sapiens)

Image does not exist
Type II interferon signaling
Therapeutics

Interactions between immune cells and microRNAs in tumor microenvironment (Homo sapiens)

Image does not exist
Interactions between immune cells and microRNAs in tumor microenvironment

edit  

Featured Pathways

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links

Personal tools